Open Government Portal

Open Data Portal Catalogue Dataset
Found 4670 records

This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products

Last Updated: Oct 1, 2023
Date Published: Sep 29, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Health product infowatch September 2022 pharmaceuticals biologics medical devices natural health products

This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.

Last Updated: Oct 1, 2023
Date Published: Sep 29, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Health product infowatch October 2022 pharmaceuticals biologics medical devices natural health products

This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products

Last Updated: Oct 1, 2023
Date Published: Sep 29, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Health product infowatch November 2022 pharmaceuticals biologics medical devices natural health products

This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products

Last Updated: Oct 1, 2023
Date Published: Sep 29, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Health product infowatch December 2022 pharmaceuticals biologics medical devices natural health products

The purpose of this Notice of Amendment is to notify about the additions of amifampridine, cedazuridine (when used in combination with another drug), etomidate, fedratinib, lefamulin, obiltoxaximab, polatuzumab vedotin, ripretinib, satralizumab and sonidegib to the Prescription Drug List (PDL) for human and/or veterinary use.

Last Updated: Oct 1, 2023
Date Published: Sep 29, 2023
Publisher: Health Canada
Formats: HTML
Keywords: notice of amendment Prescription Drug List PDL human-and-veterinary use amifampridine cedazuridine etomidate fedratinib lefamulin obiltoxaximab polatuzumab vedotin ripretinib ...

The purpose of this Notice of Amendment is to notify about the additions of fostamatinib, givosiran, lemborexant, luspatercept, ozanimod, trientine, and voretigene neparvovec to the Prescription Drug List (PDL) for human and veterinary use.

Last Updated: Oct 1, 2023
Date Published: Sep 29, 2023
Publisher: Health Canada
Formats: HTML
Keywords: notice of amendment Prescription Drug List PDL human-and-veterinary use fostamatinib givosiran lemborexant luspatercept ozanimod trientine and voretigene neparvovec.

This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.

Last Updated: Oct 1, 2023
Date Published: Sep 29, 2023
Publisher: Health Canada
Formats: HTML
Keywords: health product infoWatch January 2022 monthly publication pharmaceuticals biologics medical devices natural health products non-prescription health products

Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.

Last Updated: Oct 1, 2023
Date Published: Sep 29, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Health product infowatch February 2022 pharmaceuticals biologics medical devices natural health products

Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.

Last Updated: Oct 1, 2023
Date Published: Sep 29, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Health product infowatch March 2022 pharmaceuticals biologics medical devices natural health products

This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.

Last Updated: Oct 1, 2023
Date Published: Sep 29, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Health product infowatch April 2022 pharmaceuticals biologics medical devices natural health products